As the ASX200 enjoyed a solid performance on Tuesday, buoyed by higher gold and silver prices and strong materials sector gains, investors are increasingly looking at dividend stocks as a reliable strategy amidst fluctuating global events. In such dynamic market conditions, selecting high-quality dividend stocks can provide stability and income potential for your portfolio.

Top 10 Dividend Stocks In Australia

Name Dividend Yield Dividend Rating Vita Life Sciences (ASX:VLS) 3.58% ★★★★★☆ Treasury Wine Estates (ASX:TWE) 7.65% ★★★★★☆ Super Retail Group (ASX:SUL) 6.54% ★★★★★☆ Sugar Terminals (NSX:SUG) 8.19% ★★★★★☆ Steadfast Group (ASX:SDF) 3.71% ★★★★★☆ MFF Capital Investments (ASX:MFF) 3.60% ★★★★★☆ Kina Securities (ASX:KSL) 7.88% ★★★★★☆ Fiducian Group (ASX:FID) 4.36% ★★★★★☆ EQT Holdings (ASX:EQT) 4.47% ★★★★★☆ Accent Group (ASX:AX1) 7.53% ★★★★★☆

Click here to see the full list of 31 stocks from our Top ASX Dividend Stocks screener.

We'll examine a selection from our screener results.

New Hope

Simply Wall St Dividend Rating: ★★★★☆☆

Overview: New Hope Corporation Limited is involved in the development and operation of coal mines, with a market cap of A$3.53 billion.

Operations: New Hope Corporation Limited's revenue primarily comes from its coal mining operations in New South Wales, generating A$1.33 billion, and Queensland, which includes treasury and investments, contributing A$395.34 million.

Dividend Yield: 8.1%

New Hope's dividend yield of 8.11% ranks in the top 25% of Australian payers, but its sustainability is questionable due to a high cash payout ratio of 110.4%, indicating dividends aren't well covered by free cash flows. Although dividends have grown over the past decade, they have been volatile and unreliable, with significant annual drops. Recent shareholder-approved amendments to company bylaws may impact future strategies and dividend policies.

Take a closer look at New Hope's potential here in our dividend report. Our expertly prepared valuation report New Hope implies its share price may be lower than expected.ASX:NHC Dividend History as at Jan 2026

Servcorp

Simply Wall St Dividend Rating: ★★★★☆☆

Overview: Servcorp Limited offers executive serviced and virtual offices, coworking spaces, and a range of IT, communications, and secretarial services across Australia, New Zealand, Southeast Asia, the United States, Europe, the Middle East, North Asia, and globally with a market cap of A$673.21 million.

Operations: Servcorp Limited generates revenue through its real estate rental segment, which amounted to A$349.86 million.

Dividend Yield: 4.1%

Servcorp's dividend payments are well-covered by both earnings and cash flows, with a payout ratio of 52% and a cash payout ratio of 14.7%. Despite this strong coverage, the dividends have been volatile over the past decade, experiencing significant annual drops. Although trading at good value compared to peers, its dividend yield of 4.15% is below the top tier in Australia. Earnings growth has been robust, supporting potential future dividend stability.

Story Continues

Delve into the full analysis dividend report here for a deeper understanding of Servcorp. The analysis detailed in our Servcorp valuation report hints at an deflated share price compared to its estimated value.ASX:SRV Dividend History as at Jan 2026

Vita Life Sciences

Simply Wall St Dividend Rating: ★★★★★☆

Overview: Vita Life Sciences Limited is a healthcare company that formulates, packages, distributes, and sells vitamins and supplements across Australia and several Asian countries including Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China with a market cap of A$152.39 million.

Operations: Vita Life Sciences Limited generates its revenue primarily through the formulation, packaging, distribution, and sale of vitamins and supplements across various markets in Australia and several Asian countries.

Dividend Yield: 3.6%

Vita Life Sciences' dividends are well-supported by both earnings and cash flows, with payout ratios of 66.5% and 59.5%, respectively. The dividend yield of 3.58% is modest compared to Australia's top dividend payers, yet the company's dividends have been stable and growing over the past decade without volatility. Trading at a discount of 31.2% below its estimated fair value, Vita Life Sciences presents a reliable option for income-focused investors seeking stability in their portfolios.

Dive into the specifics of Vita Life Sciences here with our thorough dividend report. Our valuation report unveils the possibility Vita Life Sciences' shares may be trading at a discount.ASX:VLS Dividend History as at Jan 2026

Next Steps

Click through to start exploring the rest of the 28 Top ASX Dividend Stocks now. Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up. Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.

Searching for a Fresh Perspective?

Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ASX:NHC ASX:SRV and ASX:VLS.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments